A pharmaceutical physician with senior management experience gained at Pharmacia and Upjohn (Pfizer), Roche, GSK, Novimmune, Glenmark, UCB, Topivert Pharma, Karus Therapeutics and Virion Biotherapeutics. Through working extensively in drug development, from discovery to new drug approval, Penny has invaluable expertise in designing and implementing clinical development strategies in multiple therapeutic areas. Penny qualified from University College London, is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians and visiting Senior Lecturer at Kings College London.
